243 related articles for article (PubMed ID: 18376407)
21. Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
Puissant B; Roubinet F; Massip P; Sandres-Saune K; Apoil PA; Abbal M; Pasquier C; Izopet J; Blancher A
AIDS Res Hum Retroviruses; 2006 Feb; 22(2):153-62. PubMed ID: 16478397
[TBL] [Abstract][Full Text] [Related]
22. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.
Mehandru S; Poles MA; Tenner-Racz K; Jean-Pierre P; Manuelli V; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M
PLoS Med; 2006 Dec; 3(12):e484. PubMed ID: 17147468
[TBL] [Abstract][Full Text] [Related]
23. An additive effect of protective host genetic factors correlates with HIV nonprogression status.
Salgado M; Simón A; Sanz-Minguela B; Rallón NI; López M; Vicario JL; Benito JM; Rodés B
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):300-5. PubMed ID: 21084992
[TBL] [Abstract][Full Text] [Related]
24. High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients.
Yeregui E; Viladés C; Domingo P; Ceausu A; Pacheco YM; Veloso S; Inciarte A; Vidal-González J; Peraire M; Perpiñán C; Falcó V; Masip J; Alba V; Vargas M; Martí A; Reverté L; Mallolas J; Vidal F; Peraire J; Rull A
EBioMedicine; 2020 Dec; 62():103077. PubMed ID: 33166788
[TBL] [Abstract][Full Text] [Related]
25. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
26. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F
J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680
[TBL] [Abstract][Full Text] [Related]
27. The predictive role of CD4
Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
[TBL] [Abstract][Full Text] [Related]
28. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
[TBL] [Abstract][Full Text] [Related]
29. CCL3L1 and HIV/AIDS susceptibility.
Urban TJ; Weintrob AC; Fellay J; Colombo S; Shianna KV; Gumbs C; Rotger M; Pelak K; Dang KK; Detels R; Martinson JJ; O'Brien SJ; Letvin NL; McMichael AJ; Haynes BF; Carrington M; Telenti A; Michael NL; Goldstein DB
Nat Med; 2009 Oct; 15(10):1110-2. PubMed ID: 19812560
[No Abstract] [Full Text] [Related]
30. The impact of CCL3L1 copy number in an HIV-1-infected white population.
Lee EY; Yue FY; Jones RB; Lo C; Sheth P; Hyrcza MD; Kovacs C; Benko E; Kaul R; Ostrowski M
AIDS; 2010 Jun; 24(10):1589-91. PubMed ID: 20442635
[TBL] [Abstract][Full Text] [Related]
31. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.
Price P; Mathiot N; Krueger R; Stone S; Keane NM; French MA
J Clin Virol; 2001 Oct; 22(3):279-87. PubMed ID: 11564593
[TBL] [Abstract][Full Text] [Related]
32. Reply to: "Experimental aspects of copy number variant assays at CCL3L1".
He W; Kulkarni H; Castiblanco J; Shimizu C; Aluyen U; Maldonado R; Carrillo A; Griffin M; Lipsitt A; Beachy L; Shostakovich-Koretskaya L; Mangano A; Sen L; Nibbs RJ; Tiemessen CT; Bolivar H; Bamshad MJ; Clark RA; Burns JC; Dolan MJ; Ahuja SK
Nat Med; 2009 Oct; 15(10):1117-20. PubMed ID: 19812563
[No Abstract] [Full Text] [Related]
33. Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.
Brumme ZL; Brumme CJ; Chui C; Mo T; Wynhoven B; Woods CK; Henrick BM; Hogg RS; Montaner JS; Harrigan PR
J Infect Dis; 2007 Jun; 195(11):1694-704. PubMed ID: 17471440
[TBL] [Abstract][Full Text] [Related]
34. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
[TBL] [Abstract][Full Text] [Related]
35. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
Li X; Ding H; Geng W; Liu J; Jiang Y; Xu J; Zhang Z; Shang H
BMC Infect Dis; 2019 May; 19(1):373. PubMed ID: 31046702
[TBL] [Abstract][Full Text] [Related]
36. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
[TBL] [Abstract][Full Text] [Related]
37. Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.
Grünhage F; Nattermann J; Gressner OA; Wasmuth HE; Hellerbrand C; Sauerbruch T; Spengler U; Lammert F
J Hepatol; 2010 Feb; 52(2):153-9. PubMed ID: 20044164
[TBL] [Abstract][Full Text] [Related]
38. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.
Nicholson JK; Browning SW; Hengel RL; Lew E; Gallagher LE; Rimland D; McDougal JS
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):105-15. PubMed ID: 11404531
[TBL] [Abstract][Full Text] [Related]
39. Experimental aspects of copy number variant assays at CCL3L1.
Field SF; Howson JM; Maier LM; Walker S; Walker NM; Smyth DJ; Armour JA; Clayton DG; Todd JA
Nat Med; 2009 Oct; 15(10):1115-7. PubMed ID: 19812562
[No Abstract] [Full Text] [Related]
40. HIV/AIDS. HIV: experiencing the pressures of modern life.
Nolan D; James I; Mallal S
Science; 2005 Mar; 307(5714):1422-4. PubMed ID: 15746416
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]